🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates a personalized treatment strategy for patients with la...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Start Date
2026-05-14
Trial ID
NCT07602322
Treatments Being Tested
To evaluate the efficacy and side effects of Zanubrutinib combined with Obi...
Status
Recruiting
Location
Bing Xu
Start Date
2024-03-31
Trial ID
NCT06553352
Treatments Being Tested
The goal of this clinical trial is to learn the efficacy and safety of zanu...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-01
Trial ID
NCT06959732
Treatments Being Tested
The goal of this phase II randomized open label study is to compare the rat...
Status
Recruiting
Location
H. General Univ. de Alicante
Start Date
2024-09-02
Trial ID
NCT06544785
Treatments Being Tested
This clinical study examined the safety and efficacy of the combination of ...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2017-11-14
Trial ID
NCT03332017
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability; and to ...
Status
Active Not Recruiting
Location
UCLA Hematologyoncology
Start Date
2020-03-24
Trial ID
NCT04277637
Treatments Being Tested
:This is a an open-label, single-arm study to evaluate the efficacy and saf...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07
Trial ID
NCT06474481
Treatments Being Tested
The purpose of this clinical trial is to learn if the study drug Tazemetost...
Status
Active Not Recruiting
Location
Huntsman Cancer Institute at University of Uta
Start Date
2025-09-12
Trial ID
NCT06824701
Treatments Being Tested
This study is planned to prospectively evaluates the efficacy and safety of...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, Tianjin 300020
Start Date
2025-12-25
Trial ID
NCT07299149
This is a single arm, open label, national multicenter clinical study inclu...
Status
Not Yet Recruiting
Location
The First Hospital of Jilin University
Start Date
2025-06-15
Trial ID
NCT07003464
Treatments Being Tested